Narrow Your Results

Strategy

Sections

Showing 1 - 4 of 4 Results for "and Zimbabwe"

Results

Provision and Access Gap
Treatment programs need strategies to retain patients on treatment for countries affected by humanitarian emergencies (refugees of war, internally displaced people, etc.). Researchers found that patients faced challenges accessing treatment and continuing to stay on ARVs with floods, political crises and strikes.
Provision and Access
1 study
Interventions are needed to counter gender norms that discourage men from attending health services until they are extremely sick. Studies have shown that norms of masculinity prevent men from accessing ART until severely symptomatic.
Provision and Access
1 study
HIV surveillance systems do not count those over age fifty, particularly women, and treatment guidelines are missing for this age group. Currently, 4.2 million people live with HIV globally with increasing numbers of people over the age of 50 living with HIV. Few studies assess prevalence among women above age 50. Integration of treatments for common chronic diseases of old age will need to be integrated into HIV services.
Provision and Access
1 study
Barriers such as cost of medications, stigma, long clinic waits, lack of food, and child-care responsibilities, among others, may discourage women living with HIV from accessing antiretroviral therapy. A study found that patients who were living with HIV but did not access antiretroviral therapy were twice as likely as patients on antiretroviral therapy to report not having enough food to take with treatment as a concern, in addition to concerns about cost barriers. Another study found that cost of ARVs, with direct out of pocket payment at point of care delivery decreased access to ARVs. Another study found transport costs and waiting time a barrier to access to treatment. Increased efforts are needed so that those in pre-ART care understand that HIV can be transmitted prior to ART eligibility.
Provision and Access
1 study